Skip to content. | Skip to navigation


Personal tools

Katy Milne Pubs

Peer-Reviewed Papers


2014

  • Wick DA, Webb JR, Nielsen JS, Martin SD, Kroeger DR, Milne K, Castellarin M,Twumasi-Boateng K, Watson PH, Holt RA, Nelson BH. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res. 2014 Mar 1;20(5):1125-34. doi: 10.1158/1078-0432.CCR-13-2147.Epub 2013 Dec 9. [PubMed - 24323902]

 

2013

  • Webb JR, Milne K, Watson PH, Deleeuw RJ, Nelson BH, Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res. 2013 Nov 4. [Epub ahead of print] PMID 24190978
  • Castellarin M, Milne K, Zeng T, Tse K, Mayo M, Zhao Y, Webb JR, Watson PH, Nelson BH, Holt RA.Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease. J Pathol. 2013 Mar;229(4):515-24. doi: 10.1002/path.4105. Epub 2012 Nov 29.  PMID: 22996961

 

2012

  • McAlpine JN, Porter H, Köbel M, Nelson BH, Prentice LM, Kalloger SE, Senz J, Milne K, Ding J, Shah SP, Huntsman DG, Gilks CB. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Mod Pathol. 2012 May;25(5):740-50. doi: 10.1038/modpathol.2011.211. Epub 2012 Jan 27. PMID: 22282309

 

  • Milne K, Alexander C, Webb JR, Sun W, Dillon K, Kalloger SE, Gilks CB, Clarke B, Köbel M, Nelson BH. Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes.J Transl Med. 2012 Feb 27;10:33. doi: 10.1186/1479-5876-10-33. PMID:22369276
  • West NR, Kost SE, Martin SD, Milne K, Deleeuw RJ, Nelson BH, Watson PH.Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. Br J Cancer. 2012 Nov 20. doi: 10.1038/bjc.2012.524. PMID: 23169287
  • Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH, Nelson BH. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res. 2012 Jun 15;18(12):3281-92. Epub 2012 May 2. PMID: 22553348.

 

2011

  • West NR, Milne K, Truong PT, Macpherson N, Nelson BH, Watson PH. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. 2011;13(6):R126. Epub 2011 Dec 8. PMID: 22151962
  • West NR, Panet-Raymond V, Truong PT, Alexander C, Milne K, Ross LA, Loken S, Watson PH. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011; 5:105-15. Epub. 2011 May 31 [PubMed - 21695097]


2010

  • Webb JR, Wick DA, Nielsen JS, Tran E, Milne K, McMurtrie E, Nelson BH.  Profound elevation of CD8(+) T cells expressing the intraepithelial lymphocyte marker CD103 (alpha(E)/beta(7) Integrin) in high-grade serous ovarian cancer. Gynecol Oncol. 2010 Jun 9 [Epub ahead of print] [PubMed - 20541243] 


2009

  • Martin ML, Wall EM, Sandwith E, Girardin A, Milne K, Watson PH, Nelson BH. Density of tumour stroma is correlated to outcome after adoptive transfer of CD4(+) and CD8 (+) T cells in a murine mammary carcinoma model. Breast Cancer Res Treat. 2009 Sep 30. (2009).  [PubMed - 19789976] 
  • Milne K, Kobel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, Watson PH, Nelson BH. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One. 2009 Jul 29;4(7):e6412. (2009).  [PubMed - 19641607]
  • Yang T, Martin ML, Nielsen JS, Milne K, Wall EM, Lin W, Watson PH, Nelson BH. Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b gene. Cancer Immunol Immunother. 2009 Apr 7. (2009).  [PubMed - 19350239] 


2008

  • Milne K, Barnes RO, Girardin A, Mawer MA, Nesslinger NJ, Ng A, Nielsen JS, Sahota R, Tran E, Webb JR, Wong MQ, Wick DA, Wray A, McMurtrie E, Kobel M, Kalloger SE, Gilks CB, Watson PH, Nelson BH. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 3(10):e3409. Epub 2008 Oct 15. (2008).  [PubMed - 18923710]


2007

  • Wall EM, Milne K, Martin ML, Watson PH, Theiss P, Nelson BH. Spontaneous mammary tumors differ widely in their inherent sensitivity to adoptively transferred T cells. Cancer Res. 67(13):6442-50. (2007).  [PubMed - 17616705] 
  • Yang T, Wall EM, Milne K, Theiss P, Watson P, Nelson BH. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism. Clin Cancer Res. 13(23):7172-80. (2007).  [PubMed - 18056198]